Impaired NK cell differentiation of blood-derived CD34+ progenitors from patients with myeloid metaplasia with myelofibrosis

被引:16
|
作者
Briard, D
Brouty-Boyé, D
Giron-Michel, J
Azzarone, B
Jasmin, C
Le Bousse-Kerdilès, MC
机构
[1] Hop Paul Brousse, INSERM, U 268, F-94807 Villejuif, France
[2] Hop Paul Brousse, INSERM, U506, F-94807 Villejuif, France
关键词
myeloid metaplasia with myelofibrosis; blood CD34(+) cells; NK cell differentiation; IL-15; fibroblast; signaling pathway;
D O I
10.1016/S1521-6616(02)00046-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cultured blood CD34(+) progenitors from patients with myeloid metaplasia with myelofibrosis (MMM) failed to differentiate into natural killer (NK) cells with recombinant interleukin (IL)-15. No NK cells either could be induced in coculture with IL-15-expressing fibroblasts from MMM patients' spleens. The impaired NK differentiation could be circumvented by using normal blood CD34(+) cells in the coculture. In this case, cell-to-cell contact and IL-15 interaction were crucial for NK cell differentiation. Pretreatment of normal CD34(+) progenitors with anti-IL-15 monoclonal antibody markedly reduced NK cell production while MMM fibroblast pretreatment did not. Both normal and MMM progenitors constitutively expressed IL-15. Analysis of endogenous IL-15 signaling pathway revealed a constitutive gammac/Jak3 association and STAT3 activation in the two types of progenitors. Anti-IL-15 monoclonal antibody treatment caused a downregulation of IL-15 signaling in normal but not MMM blood cells. The impaired NK differentiation in MMM may thus arise from a deregulated control of an endogenous IL-15 involved in hematopoietic progenitors' lymphoid differentiation. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:201 / 212
页数:12
相关论文
共 50 条
  • [21] Identification and validation of ferroptosis related markers in erythrocyte differentiation of umbilical cord blood-derived CD34+ cell by bioinformatic analysis
    Liu, Qian
    Lin, Ze
    Yue, Minghui
    Wu, Jianbo
    Li, Lei
    Huang, Daqi
    Fang, Yipeng
    Zhang, Xin
    Hao, Tao
    FRONTIERS IN GENETICS, 2024, 15
  • [22] Enhanced HDAC (histone deacetylase) activity in blood CD34+ cells in patients with agnogenic myeloid metaplasia
    Wang, JC
    Hemavathy, K
    Suppiah, K
    Boghossian, N
    Chang, TS
    Novetsky, AD
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 105 - 105
  • [23] HUMAN DENDRITIC CELL-PROLIFERATION AND DIFFERENTIATION FROM BONE-MARROW-DERIVED CD34+ HEMATOPOIETIC PROGENITORS
    YOUNG, JW
    SZABOLCS, P
    FELLER, ED
    JIN, L
    MOORE, MAS
    BLOOD, 1993, 82 (10) : A181 - A181
  • [24] CORD BLOOD-DERIVED CD34+ EX VIVO CELL EXPANSION IN AN AUTOMATED HOLLOW FIBER BIOREACTOR
    Jones, M.
    Vang, B.
    Startz, T.
    Frank, N.
    Hill, D.
    Nankervis, B.
    Nguyen, K.
    CYTOTHERAPY, 2016, 18 (06) : S29 - S29
  • [25] Blood CD34 count in myelofibrosis with myeloid metaplasia: A prospective evaluation of prognostic value in 94 patients.
    Arora, B
    Sirhan, S
    Hoyer, JD
    Mesa, RA
    Tefferi, A
    BLOOD, 2004, 104 (11) : 191A - 191A
  • [26] Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients
    Arora, B
    Sirhan, S
    Hoyer, JD
    Mesa, RA
    Tefferi, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (01) : 42 - 48
  • [27] Differential gene expression of cord blood-derived CD34+ and CD133+ cells
    Hemmoranta, H.
    Hautaniemi, S.
    Niemi, J.
    Nicorici, D.
    Laine, J.
    Yli-Harja, O.
    Partanen, J.
    Jaatinen, T.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 70 - 70
  • [28] Lack of alteration in GATA-1 expression in CD34+ hematopoietic progenitors from patients with idiopathic myelofibrosis
    Martyré, MC
    Steunou, V
    Le Bousse-Kerdilès, MC
    Wietzerbin, J
    BLOOD, 2003, 101 (12) : 5087 - 5088
  • [29] Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells
    Yu, Y
    Hagihara, M
    Ando, K
    Gansuvd, B
    Matsuzawa, H
    Tsuchiya, T
    Ueda, Y
    Inoue, H
    Hotta, T
    Kato, S
    JOURNAL OF IMMUNOLOGY, 2001, 166 (03): : 1590 - 1600
  • [30] T-lymphopoietic capacity of cord blood-derived CD34+ progenitor cells
    Gardner, JP
    Rosenzweig, M
    Marks, DF
    Harper, D
    Gaynor, K
    Fallon, RJ
    Wall, DA
    Johnson, RP
    Scadden, DT
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (10) : 991 - 999